Cargando…
Nitazoxanide Exerts Immunomodulatory Effects on Peripheral Blood Mononuclear Cells from Type 2 Diabetes Patients
Background: Type 2 diabetes (T2D) is a low-grade inflammatory condition with abnormalities in the immune response mediated by T lymphocytes and macrophages. Drug repositioning for immunomodulatory molecules is an attractive proposal for treating T2D. Nitazoxanide (NTZ) is a broad-spectrum drug with...
Autores principales: | Castillo-Salazar, Mauricio, Sánchez-Muñoz, Fausto, Springall del Villar, Rashidi, Navarrete-Vázquez, Gabriel, Hernández-DiazCouder, Adrián, Mojica-Cardoso, Carlos, García-Jiménez, Sara, Toledano-Jaimes, Cairo, Bernal-Fernández, Germán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699442/ https://www.ncbi.nlm.nih.gov/pubmed/34944461 http://dx.doi.org/10.3390/biom11121817 |
Ejemplares similares
-
Lactobacillus isolates from healthy volunteers exert immunomodulatory effects on activated peripheral blood mononuclear cells
por: Sun, Keyi, et al.
Publicado: (2013) -
CD147 rs8259T>A Variant Confers Susceptibility to COVID-19 Infection within the Mexican Population
por: Amezcua-Guerra, Luis M., et al.
Publicado: (2023) -
Efficacy of Nitazoxanide, Nitazoxanide-Garlic Combination and Tinidazole in Treatment of Giardia duodenalis and Blastocystis hominis: Coproscopic Assessment
por: Abdo, Sarah M., et al.
Publicado: (2023) -
Nitazoxanide is active against Mycobacterium leprae
por: Bailey, Mai Ann, et al.
Publicado: (2017) -
Nitazoxanide and COVID-19: A review
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)